NCT05066243

Brief Summary

To create a new patient reported outcome measure in the form of a questionnaire, which will accurately reflect the profound impact that vulval dermatoses and vulval pain syndromes have on patients' quality of life

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
165

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2021

Shorter than P25 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 23, 2021

Completed
11 days until next milestone

First Posted

Study publicly available on registry

October 4, 2021

Completed
5 days until next milestone

Study Start

First participant enrolled

October 9, 2021

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2022

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 15, 2022

Completed
Last Updated

October 4, 2021

Status Verified

October 1, 2020

Enrollment Period

4 months

First QC Date

September 23, 2021

Last Update Submit

September 23, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • questionnaire development

    questionnaire development

    1 year

Study Arms (2)

focus group

15 service users for focus group

questionnaire

150 patients to test questionnaire

Other: questionnaire

Interventions

this study is to develop a questionnaire for vulval conditions

questionnaire

Eligibility Criteria

Age18 Years+
Sexfemale(Gender-based eligibility)
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

vulval dermatoses and vulval pain syndromes patients

You may qualify if:

  • \) Adult female patients aged 18 upwards 2) Patients must have a vulval dermatosis or vulval pain syndrome confirmed on history and examination. These will include inflammatory dermatoses, non-inflammatory dermatoses and vulval pain syndromes

You may not qualify if:

  • \) Patient with a vulval condition thought to be of a sexually transmitted aetiology 2) Patients lacking capacity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Interventions

Surveys and Questionnaires

Intervention Hierarchy (Ancestors)

Data CollectionEpidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 23, 2021

First Posted

October 4, 2021

Study Start

October 9, 2021

Primary Completion

February 1, 2022

Study Completion

April 15, 2022

Last Updated

October 4, 2021

Record last verified: 2020-10